Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Rewey Asset Management's SMID Value Composite gained 20.06% in Q2 2026, outperforming the Russell 2500 Value index which rose 18.50%, bringing year-to-date returns to 31.15%. The manager believes...
— Chip Rewey
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Orthofix Medical Inc.
No other institutional pitches found for this ticker yet.